Dashboard
Manage Tickers

MIRA MIRA PHARMACEUTICALS, INC.

Nasdaq www.mirapharmaceuticals.com


$ 1.50 $ -0.05 (-3.23 %)    

Friday, 24-Oct-2025 19:41:07 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 1.5
$ 1.59
$ 1.49 x 1
$ 1.54 x 4
$ 1.48 - $ 1.60
$ 0.73 - $ 2.56
801,795
na
28.6M
$ -0.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 09-15-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mira-pharma-initiates-multiple-ascending-dose-portion-of-ongoing-phase-1-clinical-trial-evaluating-lead-oral-candidate-ketamir-2-in-healthy-volunteers
MIRA Pharma Initiates Multiple Ascending D...
10/24/2025 11:31:12

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potenti...

mira-pharmaceuticals-initiates-the-multiple-ascending-dose-portion-of-its-ongoing-phase-1-clinical-trial-evaluating-its-lead-oral-candidate-ketamir-2-in-healthy-volunteers-advancing-toward-phase-2a-clinical-evaluation-in-chemotherapy-related-pain-a-condition-with-no-approved-treatments-and-potential-for-fda-fast-track-consideration
MIRA Pharmaceuticals Initiates The Multipl...
10/23/2025 20:48:36

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company") announced that it has initiated the multiple...

mira-pharmaceuticals-sells-1751000-shares-at-219-each
MIRA Pharmaceuticals Sells 1,751,000 Share...
10/16/2025 20:21:14

-SEC Filing

mira-pharmaceuticals-stock-surges-following-positive-preclinical-data
MIRA Pharmaceuticals Stock Surges Followin...
10/16/2025 18:16:00

MIRA Pharmaceuticals shares are trading significantly higher on Thursday following the announcement of new preclinical data for...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 17:08:00

dow-dips-over-100-points-us-crude-oil-inventories-surge
Dow Dips Over 100 Points; US Crude Oil Inv...
10/16/2025 16:31:12

dow-surges-over-100-points-charles-schwab-posts-upbeat-earnings
Dow Surges Over 100 Points; Charles Schwab...
10/16/2025 14:00:35

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 12:08:17

Core News & Articles
Market-Moving News for October 16th
10/16/2025 11:14:53

TSM: 2% | Taiwan Semiconductor Lifts Outlook After Blowout Quarter, CEO Says AI Signals From Clients Are 'Very Strong' ...

why-jb-hunt-transport-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why J.B. Hunt Transport Shares Are Trading...
10/16/2025 09:30:41

why-mira-pharmaceuticals-shares-rose-69-after-hours
Why Mira Pharmaceuticals Shares Rose 69% A...
10/16/2025 05:15:35

Mira Pharmaceuticals shares surged 68.94% in after-hours trading after the company reported promising preclinical results for ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 21:07:03

mira-pharmaceuticals-reports-new-preclinical-data-showing-that-oral-administration-of-mira-55-normalized-pain-and-significantly-reduced-inflammation-outperforming-injected-morphine-in-a-chronic-inflammatory-pain-model
Mira Pharmaceuticals Reports New Preclinic...
10/15/2025 20:06:10

https://www.sec.gov/Archives/edgar/data/1904286/0001493152-25-018141-index.html

mira-pharmaceuticals-says-phase-1-sad-study-demonstrated-that-ketamir-2-was-safe-and-well-tolerated-at-all-dose-levels
MIRA Pharmaceuticals Says Phase 1 SAD Stud...
09/22/2025 11:36:05

mira-pharmaceuticals-reports-ketamir-2-restored-normal-behavior-in-ptsd-animal-study-expands-focus-beyond-pain
MIRA Pharmaceuticals Reports Ketamir-2 Res...
09/16/2025 11:37:18

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company dev...

mira-pharmaceuticals-announces-ketamir-2-reverses-ptsd-like-symptoms-in-animal-study-supporting-ongoing-clinical-development
MIRA Pharmaceuticals Announces Ketamir-2 R...
09/15/2025 20:14:02

MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals MIRA P...

mira-pharmaceuticals-announces-ptsd-data-for-ketamir-2
Mira Pharmaceuticals Announces PTSD Data F...
09/15/2025 20:05:54

-Sec Filing

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/12/2025 17:06:17

mira-pharmaceuticals-shareholders-approve-acquisition-of-skny-pharma-adds-skny-1-oral-candidate-showing-30-weight-loss--nicotine-craving-reversal-deal-valued-at-60m-combined-entity
MIRA Pharmaceuticals Shareholders Approve ...
09/12/2025 11:32:25

mira-pharmaceuticals-completes-phase-1-single-ascending-dose-portion-of-phase-1-trial-of-ketamir-2
MIRA Pharmaceuticals Completes Phase 1 Sin...
08/19/2025 12:42:27

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION